1.	Phase III Melphalan Chemotherapy vs Intraperitoneal Radioactive Chromic Phosphate for Stage I Epithelial Ovarian Cancer Phase: Phase III Type: Treatment Status: Completed Age: no age specified Sponsor: NCI Protocol IDs: GOG-46, GOG-7862
2.	Phase III Comparison of Venesection, Radiophosphorus, and Busulphan Chemotherapy in the Treatment of Polycythemia Vera (Summary Last Modified 07/93) Phase: Phase III Type: Treatment Status: Closed Age: over 35 Sponsor: Protocol IDs: MRC-LEUK-PRV, EU-92019, UICC-73057, UKM-MRC-PT-7357
3.	Phase III Randomized Comparison of Intraperitoneal 32-P vs Combination Chemotherapy with CDDP/CTX as Adjuvant Therapy Following Complete Resection of Ovarian Carcinoma with Pelvic Extension or of Unfavorable Histology Phase: Phase III Type: Treatment Status: Completed Age: 18 to 75 Sponsor: NCI Protocol IDs: GOG-95, MAYO-876102, NCCTG-876102, NCI-87-C-12, SWOG-9047, NCI-T87-0051N, T87-0051
4.	Phase III Randomized Evaluation of Adjuvant Intraperitoneal 32-P Following Negative Second-Look Laparotomy in Patients with Stage III Epithelial Ovarian Carcinoma Phase: Phase III Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: GOG-0093, NCCTG-896151
5.	Phase III Chemotherapy with CLB/PRED and CTX/ARA-C/PRED vs Total Body Radiotherapy for Chronic Lymphocytic Leukemia Phase: Phase III Type: Treatment Status: Closed Age: no age specified Sponsor: NCI Protocol IDs: EST-3476
6.	Fluorouracil, External-Beam Radiation Therapy, and Gemcitabine With or Without Brachytherapy Using Phosphorus P32 in Treating Patients With Locally or Regionally Advanced Unresectable Adenocarcinoma of the Pancreas Phase: No phase specified Type: Treatment Status: Closed Age: 18 and over Sponsor: Other Protocol IDs: CDR0000355400, USFPG-6034, NCT00079365